May 31，Secretary of the Party Leadership Group of the Provincial Food and Drug Administration、Director Ying Hongfeng and his delegation visited Shaanxi Pharmaceutical Group，Vaccine R&D and production、Development of traditional Chinese medicine industry, etc. carry out on-site office work，Help companies solve urgent, difficult and anxious problems。Secretary stake betting appof the Party Committee of Shaanxi Pharmaceutical Group、Chairman Zhai Riqiang accompanied the investigation，Deputy Secretary of the Party Committee、General Manager Li Yuan presided over the symposium。
Ying Hongfeng and his delegation visited Northwest International Traditional Chinese Medicine Industrial Park and Xingqing Pharmaceutical Company。While visiting Gaoling Chinese Medicine City，Learn more了Chinese Medicine City Drug Inspection and Testing、Chinese medicinal materials distribution and circulation、Park service function supporting facilities, etc.，Pass marketization to Shaanxi Pharmaceutical Group、Parkization、Platformization、Integrating Chinese herbal medicine resources through capitalization and other methods，Construction of the entire modern traditional Chinese medicine industry chain is affirmed。
Visit Gaoling Chinese Medicine City
At the subsequent symposium，Shaanxi Pharmaceutical Group will build Qinchuang original Shaanxi Pharmaceutical vaccine R&My stake betting appD and Production Base、Report on the development of traditional Chinese medicine industry。Provincial Food and Drug Administration Registration Office、Production Department、The Circulation Department focuses on the vaccine production base of Shaanxi Pharmaceutical Stake Sports BettingGroup、Traditional Chinese medicine R&D and production baseetc.On-site Q&A，Help companies clarify their thinking、Streamline the process，Find the right direction、Clear Path。
Ying Hongfeng’s forward-looking plans for vaccine R&D and production of Shaanxi Pharmaceutical Group，Full recognition for promoting the development of Shaanxi vaccine industry。He emphasized，stake sports betting appVaccine R&D and production should focus on preventing disease，Priority to revitalize existing vaccine production qualifications，Innovative introduction of preventive biological products，Contribute to leading the leap-forward development of Shaanxi’s biopharmaceutical industry;The second isThe Chinese herbal medicine trading market should pay attention to standardization construction、Refined management、Refined management，Integrate superior resources and high-quality enterprises to make the distribution center bigger and stronger;Three isStrengthen communication between government and enterprises，Through effective supervision and high-quality services，Help companies solve problems and break bottlenecks，Promote the sustainable and healthy development of enterprises。
Symposium site
Shaanxi Pharmaceutical Group Human Vaccine R&My stake betting appD and Production Base Construction Project，Not only can it effectively fill the gap in the vaccine production market in Shaanxi，ImplementationIndustrial breakthrough “from 0 to 1”，It will also further promote the accelerated gathering and high-quality innovative development of Shaanxi’s biomedicine and health industries，Promoting the industrial structure of Shaanxi、Create a new economic highland、It is of great significance to realize high-quality and healthy life for the people of Sanqin。
Member of the Party Leadership Group of the Provincial Food and Drug Administration、Deputy Director Qi Huili，Office、Registry、Production Department、Relevant personnel from the Circulation Department participated in the survey。Member of the Standing Committee stake betting appof the Party Committee of Shaanxi Pharmaceutical Group、Deputy General Manager Tang Shifeng，Chief Accountant Lei Yongquan，Office、Technology Management Department，BioTechnologyThe main persons in charge of the company and Shanhaidan Pharmaceutical attended the meeting.
